| Thromboelastographic study of biomaterials. | |
| | |
MedLine Citation:
|
PMID: 20586076 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Thromboelastography (TEG) is drawing more attention for clinical and in vitro studies of blood coagulation. It can be applied to evaluate the effects of both blood-soluble and insoluble biomaterials on whole blood coagulation from the beginning of coagulation through clot formation to the ending with fibrinolysis. TEG may also identify the relative contributions of various clotting factors, such as fibrinogen and platelets, to the overall coagulation process based on profiles of its variables using whole and partial blood components. A comprehensive review has been conducted on its applications for the assessment of a wide range of blood-contacting biomaterials ranging from polymers to ceramics and biomedical devices involved in many applications. The methodology is different in terms of instrumentation, the methods to activate blood coagulation, the type of blood (citrated versus fresh blood), and study settings (in vitro, in vivo, and clinical trials). The author's own work and future directions are discussed as well. TEG should be considered as one of the most useful tools for evaluating in vitro and in vivo blood-biomaterial interactions for different applications. |
| | |
Authors:
|
Henry T Peng |
Related Documents
:
|
12054376 - Effect of variable tinted spectacle lenses on visual performance in control subjects. 12819506 - The relationship between five kinds of laparoscopic knots and five types of suture mate... 15704256 - Hyperhomocysteinemia, thrombosis and vascular biology. 16407946 - A magnetic reconnection x-line extending more than 390 earth radii in the solar wind. 2299746 - Glucagon potentiates intestinal reperfusion injury. 21511866 - Diffusion-weighted imaging of hyperacute cerebral hypoglycemia. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of biomedical materials research. Part B, Applied biomaterials Volume: 94 ISSN: 1552-4981 ISO Abbreviation: J. Biomed. Mater. Res. Part B Appl. Biomater. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-07 Completed Date: 2010-10-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101234238 Medline TA: J Biomed Mater Res B Appl Biomater Country: United States |
Other Details:
|
Languages: eng Pagination: 469-85 Citation Subset: IM |
Affiliation:
|
Defence Research and Development Canada-Toronto, 1133 Sheppard Avenue West, Toronto, Ontario M3M3B9, Canada. henry.peng@drdc-rddc.gc.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biocompatible Materials
/
pharmacology*,
therapeutic use Blood Coagulation / drug effects* Equipment and Supplies / standards Humans Thrombelastography / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Biocompatible Materials |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surface hydrophobicity, nutritional contents affect Staphylococcus aureus biofilms and temperature i...
Next Document: Corrosion behavior of nitinol in blood serum and PBS containing amino acids.